Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual?
dc.contributor.author | Wish, Jay B. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2020-03-26T14:21:49Z | |
dc.date.available | 2020-03-26T14:21:49Z | |
dc.date.issued | 2019-07 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Wish, J. B. (2019). Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual? Advances in Chronic Kidney Disease, 26(4), 225–228. https://doi.org/10.1053/j.ackd.2019.05.006 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/22415 | |
dc.language.iso | en | en_US |
dc.publisher | ACKD | en_US |
dc.relation.isversionof | 10.1053/j.ackd.2019.05.006 | en_US |
dc.relation.journal | Advances in Chronic Kidney Disease | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | anemia treatment | en_US |
dc.subject | erythropoietic stimulating agents | en_US |
dc.subject | HIF stabilizers | en_US |
dc.title | Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual? | en_US |
dc.type | Article | en_US |